alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
R E C E V E D

7fl8 MAR 21 A II : 3

Debra P. Hackett

Clerk, U.S. District Court

15 LEE ST STE 206

MONTGOMERY AL 36104-4055

March 20, 2008

Appeal Number: 07-11402-BB

Case Style: USA v. Ronald McQueen

District Court Number: 06-00 198 CR-W-N

TO: Debra P. Hackett

CC: Administrative File

Case 2:06-cr-00198-WKW-CSC Document 63 Filed 03/21/2008 Page 1 of 2
United States Court of Appeals

Eleventh Circuit

56 Forsyth Street, N.W.

Atlanta, Georgia 30303

Thomas K Kahn ' Zo4$end forms visit

Clerk www.cal 1.uscourts.gov

1i 2' March 20, 2008 A 1/: 3

Debra P. Hackett

Clerk, U.S. District Court

15 LEE ST STE 206

MONTGOMERY AL 36104-4055

Appeal Number: 07-11402-BB

Case Style: USA v. Ronald McQueen

District Court Number: 06-00198 CR-W-N

The following record materials in the referenced case are returned herewith:

Record on Appeal VOL(S) four volumes

Exhibits - one envelope, one psi

The clerk of the court or agency shown above is requested to acknowledge receipt on the copy of

this letter enclosed to the clerk.

Sincerely,

THOMAS K. KAHN, Clerk

Reply To: James 0. Delaney (404) 335-6113

REC-3 (06-2006)

Case 2:06-cr-00198-WKW-CSC Document 63 Filed 03/21/2008 Page 2 of 2
2128.370 Contract clause.

The contract clause at FAR 52.228-7 is a mandatory clause in FEGLI Program contracts, except

paragraph (d) is modified as follows:

(d) The Government's liability under paragraph (c) of this clause is limited to the amount available in

the Employee's Life Insurance Fund. Nothing in this contract shall be construed as implying that the

Government will make additional funds available later or that Congress will appropriate funds later

sufficient to meet deficiencies.

Parent topic: Subpart 2128.3 - Insurance
H. Res. 1101

In the House of Representatives, U. S., 

December 8, 2006.

Resolved, That upon the adoption of this resolution it 

shall be in order to consider the conference report to accompany the bill (H.R. 5682) to exempt from certain requirements of the Atomic Energy Act of 1954 a proposed nuclear 

agreement for cooperation with India. All points of order 

against the conference report and against its consideration 

are waived. The conference report shall be considered as read. 

Attest:

Clerk.
§ 217.43 Criteria for assistance. Requests for special priorities assistance should be timely, *i.e.,* the request has been submitted promptly and enough time exists for the Department of Energy, the Delegate Agency, or the Department of Commerce for industrial resources to effect a meaningful resolution to the problem, and must establish that: ( a ) There is an urgent need for the item; and
( b ) The applicant has made a reasonable effort to resolve the problem.
Editorial Note on Part 32
Editorial Note: Nomenclature changes to part 32 appear at 79 FR 75739, Dec. 19, 2014.

§ 32.14 Certain items containing byproduct material; requirements for license to apply or initially transfer. An application for a specific license to apply byproduct material to, or to incorporate byproduct material into, the products specified in § 30.15 of this chapter or to initially transfer for sale or distribution such products containing byproduct material for use pursuant to § 30.15 of this chapter will be approved if: ( a ) The applicant satisfies the general requirements specified in § 30.33 of this chapter;
( b ) The applicant submits sufficient information regarding the product pertinent to evaluation of the potential radiation exposure, including: ( 1 ) Chemical and physical form and maximum quantity of byproduct material in each product;
( 2 ) Details of construction and design of each product;
( 3 ) The method of containment or binding of the byproduct material in the product;
( 4 ) Except for electron tubes and ionization chamber smoke detectors and timepieces containing promethium-147 or tritium in the form of gaseous tritium light sources, procedures for and results of prototype testing to demonstrate that the byproduct material will not become detached from the product and that the byproduct material will not be released to the environment under the most severe conditions likely to be encountered in normal use of the product;
( 5 ) In the case of ionizing radiation measuring instruments and timepieces containing tritium in the form of paint, quality control procedures to be followed in the fabrication of production lots of the product and the quality control standards the product will be required to meet;
( 6 ) The proposed method of labeling or marking each unit, except timepieces or hands or dials containing tritium or promethium-147, and its container with the identification of the manufacturer or initial transferor of the product and the byproduct material in the product;
( 7 ) For products for which limits on levels of radiation are specified in § 30.15 of this chapter, the radiation level and the method of measurement;
( 8 ) Any additional information, including experimental studies and tests, required by the Commission to facilitate a determination of the safety of the product.
( c ) Each product will contain no more than the quantity of byproduct material specified for that product in § 30.15 of this chapter. The levels of radiation from each product containing byproduct material will not exceed the limits specified for that product in § 30.15 of this chapter.
( d ) The Commission determines that the byproduct material is properly contained in the product under the most severe conditions that are likely to be encountered in normal use and handling.
[31 FR 5316, Apr. 2, 1966, as amended at 34 FR 6652, Apr. 18, 1969; 43 FR 6922, Feb. 17, 1978; 63 FR 32971, June 17, 1998; 72 FR 58487, Oct. 16, 2007; 77 FR 43691, July 25, 2012]
Subpart 1348.1 - Policies and Procedures    **Parent topic:** PART 1348 - VALUE ENGINEERING1348.102 Policies.       (a) Contracting activities shall send contractor-submitted Value Engineering Change Proposals (VECPs) to the appropriate technical personnel for review.          (b) Technical personnel shall conduct a comprehensive review of VECPs for technical feasibility, usefulness, and adequacy of the contractor's estimate of cost savings; make a written report; and recommend acceptance or rejection to the contracting officer.          (c) The designee authorized to grant exemptions from value engineering provisions in appropriate supply, service, architect-engineer and construction contracts is set forth in CAM 1301.70.
#### SILVERMAN v. CHARLES JACOBS CO.

(Supreme Court, Appellate Term, First Department.

December 24, 1914.)

Api’eal and Ebeob (§ 1175*)—Review—Disposition of Cause.

Where plaintiff in an action for an alleged breach of contract failed to prove a cause of action either at the first or second trial, a judgment in his favor will be reversed, and the complaint dismissed.

[Ed. Note.—For other cases, see Appeal and Error, Cent. Dig. §§ 4573-4587; Dec. Dig. § 1175.*]

Appeal from Municipal Court, Borough of Manhattan, Seventh District.

Action by Julius Silverman against the Charles Jacobs Company. From a Municipal Court judgment in favor of the plaintiff, entered on the jury’s verdict, defendant appeals. Reversed and dismissed.

See, also, 146 N. Y. Supp. 1067.

Argued December term, 1914, before GUY, BIJUR, and PAGE, JJ.

Engel Bros., of New York City (Isidore Schneider, of New York City, of counsel), for appellant.

Henry Salant, of New York City, for respondent.

BIJUR, J.

Plaintiff sues defendant, an auctioneer, for breach of an agreement not to sell goods delivered to the auctioneer for less than a certain invoice price. Defendant rested on its motion to dismiss at the close of plaintiff’s case.

Plaintiff failed to prove any cause of action, either against defendant or any one else; and as this is the second trial of this suit,- and it is evident that plaintiff is unable to furnish proof to sustain his complaint, the judgment is reversed, with costs, and the complaint dismissed, with costs. All concur.
Exhibit No. 12.

Questar Pipeline Company
Ratio of Earnings to Fixed Charges
<TABLE>
<CAPTION>
                                                12 months ended March 31,
                                                    1998        1999
                                                (Dollars in Thousands)
<S>                                             <C>         <C>
Earnings

Income before income taxes                          $42,548     $44,325
Plus debt expense                                    13,619      15,199
Plus allowance for borrowed
   funds used during construction                       226       1,326
Plus interest portion of rental expense                 263         342
                                                    $56,656     $61,192

Fixed Charges

Debt expense                                        $13,619     $15,199
Plus allowance for borrowed
   funds used during construction                       226       1,326
Plus interest portion of rental expense                 263         342
                                                    $14,108     $16,867

Ratio of Earnings to Fixed Charges                     4.02        3.63
</TABLE>
Exhibit 32.2





CERTIFICATION OF THE PRINCIPAL FINANCIAL OFFICER


Pursuant to 18 U.S.C. § 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of Kindred Biosciences, Inc. (the “Company”) hereby certifies that, to his knowledge:


(i)    The annual report on Form 10-K of the Company for the fiscal year ended December 31, 2013 (the “Report”) fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and


(ii)    The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.











Date:  March 14, 2014By:/s/ Stephen S. GallikerName:   Stephen S. GallikerTitle:   Chief Financial Officer
IN THE UNITED STATES DISTRICT COURT 

MIDDLE DISTRICT OF ALABAMA

NORTHERN DIVISION

UNITED STATES OF AMERICA )

)

vs. ) CR NO. 2:06cr193-MEF-CSC

)

JOSHUA WAYNE HESTER )

ORDER

For good cause, it is

ORDERED that a final pretrial conference be and is hereby set for November 13,

2006 at 1:00 p.m. in Courtroom 4B, United States Courthouse Complex, One Church Street,

Montgomery, Alabama. 

That all applicable deadlines contained in the prior arraignment order and pretrial

order are adjusted accordingly, provided, however that the deadline for the filing of pretrial,

dispositive motions is not extended.

Done this 17 day of October, 2006. th

 /s/Charles S. Coody 

CHARLES S. COODY

CHIEF UNITED STATES MAGISTRATE JUDGE

Case 2:06-cr-00193-MEF-CSC Document 31 Filed 10/17/2006 Page 1 of 1
Subpart 2812.3 - Solicitation Provisions and

Contract Clauses for the Acquisition of

Commercial Items

Parent topic: PART 2812 - ACQUISITION OF COMMERCIAL ITEMS

2812.301 Solicitation provisions and contract clauses for the

acquisition of commercial items.

Contracting officers shall include the provisions and clauses at JAR 2852.212-4 in all solicitations

and contracts for the acquisition of commercial items that require FAR 52.212-4, Contract Terms

and Conditions - Commercial Items.

2812.302 Tailoring of provisions and clauses for the

acquisition of commercial items.

The HCA, or designee at a level at or above the BPC, is authorized to approve the contracting

officer's request for waiver for an individual contract action submitted under FAR 12.302(c). The

SPE is authorized to approve the contracting officer's request for wavier for a class of contracts

submitted under FAR 12.302(c).
In the United States Court of Federal Claims 

OFFICE OF SPECIAL MASTERS

No. 11-171V

Filed: October 23, 2014

Not for Publication

*************************************

KAMALI SAMINATHAN, *

*

 Petitioner, * Attorneys’ fees and costs decision based on

 * stipulation of fact

v. *

 *

SECRETARY OF HEALTH *

AND HUMAN SERVICES, *

 *

 Respondent. *

*

*************************************

Jay A. Bansal, Tempe, AZ, for petitioner.

Glenn A. MacLeod, Washington, DC, for respondent.

MILLMAN, Special Master

DECISION AWARDING ATTORNEYS’ FEES AND COSTS1

On October 23, 2014, the parties filed a stipulation of fact in which they agreed on an 

appropriate amount for attorneys’ fees and costs in this case. 

In accordance with the General Order #9 requirement, petitioner asserts that she did not 

incur any costs in pursuit of her petition. Petitioner submitted her request for attorneys’ fees and 

costs to respondent. During informal discussions, respondent raised objections to certain items in

petitioner’s application. Based on these objections, petitioner amends her application for 

 

1 Because this unpublished decision contains a reasoned explanation for the special master’s action in this 

case, the special master intends to post this unpublished decision on the United States Court of Federal 

Claims’s website, in accordance with the E-Government Act of 2002, Pub. L. No. 107-347, 116 Stat. 2899, 

2913 (Dec. 17, 2002). Vaccine Rule 18(b) states that all decisions of the special masters will be made 

available to the public unless they contain trade secrets or commercial or financial information that is 

privileged and confidential, or medical or similar information whose disclosure would constitute a clearly 

unwarranted invasion of privacy. When such a decision is filed, petitioner has 14 days to identify and 

move to redact such information prior to the document=s disclosure. If the special master, upon review, 

agrees that the identified material fits within the banned categories listed above, the special master shall 

redact such material from public access.
2

attorneys’ fees and costs to $105,656.21. Respondent does not object to this amount. The 

undersigned finds this amount to be reasonable. Accordingly, the court awards $105,656.21, 

representing reimbursement for attorneys’ fees and costs. The award shall be in the form of a 

check payable jointly to petitioner and the Law Offices of Jay A. Bansal in the amount of 

$105,656.21.

In the absence of a motion for review filed pursuant to RCFC Appendix B, the clerk of the 

court is directed to enter judgment herewith.2

IT IS SO ORDERED.

Dated: October 23, 2014 s/ Laura D. Millman

 Laura D. Millman

 Special Master

 

2

Pursuant to Vaccine Rule 11(a), entry of judgment can be expedited by each party, either separately or 

jointly, filing a notice renouncing the right to seek review.
#### § 948.76 Budget.

As soon as practicable after the beginning of each fiscal period and as may be necessary thereafter, each area committee shall prepare an estimated budget of income and expenditures necessary for its administration of this part. Each area committee may recommend a rate of assessment calculated to provide adequate funds to defray its proposed expenditures. Each area committee shall present such budget to the Secretary with an accompanying report showing the basis for its calculations.
Case 2:06-mc-03334-MHT Document 2 Filed 10/05/2006 Page 1 of 9
Case 2:06-mc-03334-MHT Document 2 Filed 10/05/2006 Page 2 of 9
Case 2:06-mc-03334-MHT Document 2 Filed 10/05/2006 Page 3 of 9
Case 2:06-mc-03334-MHT Document 2 Filed 10/05/2006 Page 4 of 9
Case 2:06-mc-03334-MHT Document 2 Filed 10/05/2006 Page 5 of 9
Case 2:06-mc-03334-MHT Document 2 Filed 10/05/2006 Page 6 of 9
Case 2:06-mc-03334-MHT Document 2 Filed 10/05/2006 Page 7 of 9
Case 2:06-mc-03334-MHT Document 2 Filed 10/05/2006 Page 8 of 9
Case 2:06-mc-03334-MHT Document 2 Filed 10/05/2006 Page 9 of 9
**EXHIBIT 32.1CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTEDPURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

       In connection with the quarterlyreport of CNB Corporation on Form 10-Q for the period ending March 31, 2010 asfiled with the Securities and Exchange Commission on the date hereof, I, W.Jennings Duncan, President and Chief Executive Officer of CNB Corporation,certify to the best of my knowledge, pursuant to 18 U.S.C. Section 1350, asadopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 that:
| 1.     | The  above-listed Form 10-Q fully complies with the requirements of Section 13(a)  or 15(d) of the Securities Exchange Act of 1934; and                                 |
|--------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|   |                                                                                                                                                                         |
| 2.     | The  information contained in the above-listed Form 10-Q fairly presents, in all  material respects, the financial condition and results of operations of the  Company. |

 
| Date:   May 10, 2010 | /s/W. Jennings Duncan                      W. Jennings  Duncan  President and Chief Executive Officer |
|---------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|                           |                                                                                                                                                                                                                     |
<TABLE> <S> <C>


<ARTICLE>                           5
<LEGEND>

This schedule  contains  summary  financial  information  extracted from Century
Pension  Income Fund XXIII Estate  Associates III 2000 Second Quarter 10-QSB and
is qualified in its entirety by reference to such 10-QSB filing.

</LEGEND>

<CIK>                               0000764543
<NAME>                              Century Pension Income Fund XXIII
<MULTIPLIER>                                           1,000


<S>                                   <C>
<PERIOD-TYPE>                       6-MOS
<FISCAL-YEAR-END>                   DEC-31-2000
<PERIOD-START>                      APR-01-2000
<PERIOD-END>                        JUN-30-2000
<CASH>                                                 3,294
<SECURITIES>                                               0
<RECEIVABLES>                                          1,417
<ALLOWANCES>                                               0
<INVENTORY>                                                0
<CURRENT-ASSETS>                                           0 <F1>
<PP&E>                                                12,933
<DEPRECIATION>                                             0
<TOTAL-ASSETS>                                        38,658
<CURRENT-LIABILITIES>                                      0 <F1>
<BONDS>                                               58,794
<PREFERRED-MANDATORY>                                      0
<PREFERRED>                                                0
<COMMON>                                                   0
<OTHER-SE>                                                 0
<TOTAL-LIABILITY-AND-EQUITY>                          61,265
<SALES>                                                    0
<TOTAL-REVENUES>                                           0
<CGS>                                                      0
<TOTAL-COSTS>                                              0
<OTHER-EXPENSES>                                           0
<LOSS-PROVISION>                                           0
<INTEREST-EXPENSE>                                         0
<INCOME-PRETAX>                                            0
<INCOME-TAX>                                               0
<INCOME-CONTINUING>                                        0
<DISCONTINUED>                                             0
<EXTRAORDINARY>                                            0
<CHANGES>                                                  0
<NET-INCOME>                                               0
<EPS-BASIC>                                             0.00 <F2>
<EPS-DILUTED>                                              0
<FN>

<F1> Registrant has an unclassified balance sheet. <F2> Multiplier is 1.

</FN>


</TABLE>
IN THE DISTRICT COURT OF THE UNITED STATES FOR THE

MIDDLE DISTRICT OF ALABAMA, NORTHERN DIVISION

CAMELLIA THERAPEUTIC )

FOSTER AGENCY, LLC, etc., )

)

Plaintiff, )

) CIVIL ACTION NO.

v. ) 2:06cv735-MHT

)

THE ALABAMA DEPARTMENT )

OF HUMAN RESOURCES, )

)

Defendant. ) 

ORDER

For good cause shown, it is ORDERED that, pursuant to

28 U.S.C.A. § 636, this case is referred to the United

States Magistrate Judge assigned to this case for

consideration and disposition or recommendation on all

pretrial matters as may be appropriate.

DONE, this the 6th day of February, 2007.

 /s/ Myron H. Thompson 

UNITED STATES DISTRICT JUDGE

Case 2:06-cv-00735-MHT-CSC Document 22 Filed 02/06/2007 Page 1 of 1
370.701 Solicitation provision.       The contracting officer shall insert the provision at 352.270-9, Non-Discrimination for Conscience, in solicitations valued at more than the micro-purchase threshold:          (a) In connection with the implementation of HIV/AIDS programs under the President's Emergency Plan for AIDS Relief established by the United States Leadership Against HIV/AIDS, Tuberculosis and Malaria Act of 2003, as amended; or          (b) Where the contractor will receive funding under the United States Leadership Against HIV/AIDS, Tuberculosis and Malaria Act of 2003, as amended. In resolving any issues or complaints that offerors may raise regarding meeting the requirements specified in the provision, the contracting officer shall consult with the Office of Global Health Affairs, Office of the General Counsel, the Program Manager, and other HHS officials, as appropriate.    **Parent topic:** Subpart 370.7 - Acquisitions Under the Leadership Act
SUBPART 28.1 – BONDS AND OTHER

FINANCIAL PROTECTIONS

(Revised March 29, 2016 through PROCLTR 2016-06)

Parent topic: PART 28 – BONDS AND INSURANCE

28.106 Administration.

28.106-90 Review of bonds and consent of surety.

Contracting officers shall obtain legal sufficiency from Office of Counsel on all bonds and all

consents of surety.